Insider trading

Period: 120 months Stock: GLSI Plan: Not stated × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

59 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

59 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

59 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

59 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
59 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
59 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

59 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
15 Mar 2023
Thompson Jaye VP Clinical Reg Affairs
Bought
$3.18K 250 at 12.71
0.1%
10 Mar 2023
Patel Snehal CEO and CFO
Bought
$12.12K 1,000 at 12.12
0.0%
24 Feb 2023
Thompson Jaye VP Clinical Reg Affairs
Bought
$3.85K 250 at 15.40
0.1%
17 Feb 2023
Patel Snehal CEO and CFO
Bought
$9.92K 600 at 16.53
0.0%
10 Feb 2023
Patel Snehal CEO and CFO
Bought
$18.68K 1,000 at 18.68
0.0%
3 Feb 2023
Thompson Jaye VP Clinical Reg Affairs
Bought
$5.21K 250 at 20.84
0.1%
27 Jan 2023
Patel Snehal CEO and CFO
Bought
$38.70K 2,000 at 19.35
0.1%
27 Jan 2023
Thompson Jaye VP Clinical Reg Affairs
Bought
$4.80K 250 at 19.20
0.1%
20 Jan 2023
Patel Snehal CEO and CFO
Bought
$26.06K 1,500 at 17.37
0.1%
13 Jan 2023
Thompson Jaye VP Clinical Reg Affairs
Bought
$4.13K 250 at 16.50
0.1%
6 Jan 2023
Patel Snehal CEO and CFO
Bought
$22.77K 1,500 at 15.18
0.1%
29 Dec 2022
Patel Snehal CEO and CFO
Bought
$60.76K 4,000 at 15.19
0.1%
16 Dec 2022
Patel Snehal CEO and CFO
Bought
$13.01K 1,000 at 13.01
0.0%
16 Dec 2022
Thompson Jaye VP Clinical Reg Affairs
Bought
$3.24K 250 at 12.94
0.1%
9 Dec 2022
Patel Snehal CEO and CFO
Bought
$26.22K 2,000 at 13.11
0.1%
2 Dec 2022
Patel Snehal CEO and CFO
Bought
$13.84K 1,000 at 13.84
0.0%
2 Dec 2022
Thompson Jaye VP Clinical Reg Affairs
Bought
$3.50K 250 at 13.98
0.1%
2 Nov 2022
Patel Snehal CEO and CFO
Bought
$17.58K 2,000 at 8.79
0.1%
14 Oct 2022
Patel Snehal CEO and CFO
Bought
$29.25K 3,000 at 9.75
0.1%
7 Oct 2022
Patel Snehal CEO and CFO
Bought
$19.44K 2,000 at 9.72
0.1%
30 Sep 2022
Patel Snehal CEO and CFO
Bought
$9.46K 1,000 at 9.46
0.0%
29 Sep 2022
Patel Snehal CEO and CFO
Bought
$9.23K 1,000 at 9.23
0.0%
24 Jun 2022
Patel Snehal CEO and CFO
Bought
$205.74K 22,535 at 9.13
0.8%
Largest buy in 3 yrs
24 Jun 2022
Patel Snehal CEO and CFO · indirect
Bought
$59.03K 6,465 at 9.13
0.2%
16 Jun 2022
Patel Snehal CEO and CFO
Bought
$57.04K 8,000 at 7.13
0.3%
14 Jun 2022
Patel Snehal CEO and CFO
Bought
$94.92K 12,000 at 7.91
0.5%
10 Jun 2022
Patel Snehal CEO and CFO
Bought
$99.96K 12,000 at 8.33
0.5%
9 Jun 2022
Patel Snehal CEO and CFO
Bought
$49.05K 4,500 at 10.90
0.4%
7 Jun 2022
Patel Snehal CEO and CFO
Bought
$51.30K 6,000 at 8.55
0.5%
3 Jun 2022
Patel Snehal CEO and CFO
Bought
$77.24K 9,250 at 8.35
0.8%
2 Jun 2022
Patel Snehal CEO and CFO
Bought
$49.99K 6,774 at 7.38
0.6%
25 Apr 2022
Daugherty Frank Joseph Chief Medical Officer
Bought
$16.25K 1,000 at 16.25
1.1%
21 Apr 2022
Patel Snehal CEO and CFO
Bought
$96.54K 6,000 at 16.09
0.5%
19 Apr 2022
Patel Snehal CEO and CFO
Bought
$100.44K 6,000 at 16.74
0.5%
19 Apr 2022
Thompson Jaye VP Clinical Reg Affairs
Bought
$8.37K 500 at 16.74
0.2%
11 Feb 2022
Patel Snehal CEO and CFO
Bought
$108.90K 5,500 at 19.80
0.5%
Largest buy in 3 yrs
4 Feb 2022
Patel Snehal CEO and CFO
Bought
$97.95K 5,000 at 19.59
0.4%
31 Jan 2022
Thompson Jaye VP Clinical Reg Affairs
Bought
$9.24K 500 at 18.47
0.2%
21 Jan 2022
Thompson Jaye VP Clinical Reg Affairs
Bought
$8.17K 500 at 16.33
0.2%
21 Jan 2022
Hallock Kenneth Director
Bought
$4.90K 300 at 16.32
0.1%
18 Jan 2022
Thompson Jaye VP Clinical Reg. Affairs
Bought
$9.44K 500 at 18.87
0.2%
13 Jan 2022
Patel Snehal CEO and CFO
Bought
$19.99K 1,000 at 19.99
0.1%
13 Jan 2022
Thompson Jaye VP Clinical Reg. Affairs
Bought
$19.99K 1,000 at 19.99
0.4%
First buy on file
13 Jan 2022
Daugherty Frank Joseph Chief Medical Officer
Bought
$19.99K 1,000 at 19.99
1.1%
3 Jan 2022
Patel Snehal CEO and CFO
Bought
$48.83K 2,050 at 23.82
0.2%
14 Dec 2021
Patel Snehal CEO and CFO
Bought
$49.99K 1,840 at 27.17
0.2%
14 Dec 2021
Daugherty Frank Joseph Chief Medical Officer
Bought
$29.98K 1,111 at 26.99
1.3%
Largest buy in 3 yrs
14 Dec 2021
McWilliams David Director
Bought
$5.51K 200 at 27.56
0.0%
13 Apr 2021
Patel Snehal CEO and CFO
Bought
$99.85K 2,700 at 36.98
0.2%
Largest buy in 3 yrs
24 Nov 2020
Hallock Kenneth Director · indirect
Bought
$5.39K 1,000 at 5.39
0.3%
Largest buy in 3 yrs
Showing 1–50 of 59. Page 1 of 2 Older →